NEWS
![]() FDA approves first self-balancing exoskeleton for spinal cord patientsThe U.S. Food and Drug Administration (FDA) has approved the commercial sale of Eve, a personal exoskeleton developed by the French company Wandercraft. This device enables individuals with spinal cord injuries to stand and move independently, maintaining their balance without the use of a cane or walker. This is a news summary compiled for the AiPulse newsletter — not the original article. The original article is at newatlas.com. Read the original article AI Critique → English (automatic translation) |
